Dronedarone hydrochloride reverses obesity-related metabolic syndrome while preserving skeletal muscle mass
Lei, J.; Zhang, X.; cao, x.; zhu, z.; ye, f.; xu, z.; su, w.; zeng, x.; xu, z.; zhao, j.; jiang, s.; zhao, n.; Liu, H.; Lu, Y.; Sun, C.; Chai, J.
Show abstract
Obesity-driven metabolic syndrome poses a critical global threat, yet standard therapies like GLP-1 receptor agonists trigger substantial lean mass wasting, with muscle loss accounting for up to 40% of reduced weight. Here we identify a non-canonical metabolic application for dronedarone hydrochloride, an anti-arrhythmic benzofuran derivative. In diet-induced and ob/ob obese mice, short-term dronedarone hydrochloride administration dose-dependently reduces food intake, clears visceral and subcutaneous adiposity, and reverses steatohepatitis. Head-to-head trials show that dronedarone hydrochloride achieves glycemic control and fat clearance non-inferior to semaglutide, tirzepatide, and empagliflozin, but uniquely and completely preserves skeletal muscle mass. Mechanistically, dronedarone hydrochloride operates independently of central hypothalamic appetite-regulating neuropeptides and the peripheral leptin pathway. By decoupling fat reduction from sarcopenia, our findings establish dronedarone hydrochloride as a muscle-sparing therapeutic candidate for metabolic syndrome.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Gene Knockout of Angiotensin II Type 1a Receptor Improves High-fat Diet-Induced Obesity in rat via Promoting Adipose Lipolysis 96%
- Role of CCK1 receptor in metabolic benefits of intestinal enteropeptidase inhibition in mice 95%
- Metabolic differences and differentially expressed genes between C57BL/6J and C57BL/6N mice substrains 95%
Similar papers in this journal
- Mucin-mimetic action of capsaicin improves high fat diet-induced gut barrier dysfunction in mice colon 94%
- Metformin modulates microbiota-derived inosine and ameliorates methamphetamine-induced anxiety and depression-like withdrawal symptoms in mice 92%
- Abnormal Cannabidiol protects pancreatic beta cells in mouse models of experimental Type 1 diabetes 92%
Similar papers in this journal
- The protective roles of Eugenol on type 1 diabetes mellitus through NRF2 mediated oxidative stress pathway 96%
- TXN, a Xanthohumol Derivative, Attenuates High-Fat Diet Induced Hepatic Steatosis by Antagonizing PPARγ 95%
- Constitutively active receptor ADGRA3 signaling induces adipose thermogenesis 95%
Similar papers in this journal
- Daily transient coating of the intestine leads to weight loss and improved glucose tolerance 97%
- PPARalpha-ERRalpha crosstalk mitigates metabolic dysfunction-associated steatotic liver disease progression 93%
- Hypothalamic C2-domain protein involved in MC4R trafficking and control of energy balance 93%
Similar papers in this journal
- Effects of systemic oxytocin and beta-3 receptor agonist (CL 316243) treatment on body weight and adiposity in male diet-induced obese rats 94%
- GLP-1 Receptor Agonist Improves Metabolic Disease in a Pre-clinical Model of Lipodystrophy 94%
- The Novel Chimeric Multi-Agonist Peptide (GEP44) Reduces Energy Intake and Body Weight in Male and Female Diet-Induced Obese Mice in a Glucagon-Like Peptide-1 Receptor-Dependent Manner 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.